Additional Information

Dr. Qun Jiang is a cancer immunologist at NCI. Dr. Jiang received her Ph.D. from the University of Science and Technology of China in 2008, where she studied the roles of the innate immune system in anti-tumor immunity and inflammatory liver injury. She was then a postdoc with Dr. Robert H. Wiltrout at NCI-Frederick, where she studied the inflammation-associated tumorigenesis and developed novel cancer immunotherapy strategies. In 2015, she joined Dr. Raffit Hassan’s group as a staff scientist in Thoracic and GI Malignancies branch at NCI. Her current research focuses on mesothelin-targeted immunotherapy for solid tumors treatments. She has won the NCI Director’s Innovation Award in 2020 and Mesothelioma Applied Research Foundation grant in 2021.

Areas of Expertise

1) Cancer Immunology and Immunotherapy 2) Tumor modeling 3) Genome-editing and T/NK cellular therapy 4) iPSC-derived immunotherapy